CLINICAL_TRIALS
research
· 2024-10-02
Clinical Trial Update: Safety and Efficacy of AR1005 in Patients with Lewy Body Disease [Phase 2]
Summary
Phase 2 clinical trial evaluating AR1005 for safety and efficacy in Lewy body dementia is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yonsei University | Conditions: Lewy Body Dementia | Phase 2 | Status: RECRUITING